Dr. Greenwald joined Hemedex, Inc. in 2012 bringing 20 years of experience managing innovative, early-phase development of novel medical devices, most notably the Bispectral Index (BIS) developed by Aspect Medical Systems. Dr. Greenwald has expertise in biomedical signal processing, analytics and outcomes research, and is a significant individual contributor as co-inventor of 3 novel patient monitoring technologies (BIS, CVI, and ATR), co-author of 8 US Patents, and co-author of 100+ publications that support the development, clinical utility, and benefits of the technologies he helped to develop. Prior to joining Hemedex, he served Covidien (3yrs) as Sr. Director of Advanced Research for the Respiratory and Patient Monitoring business unit. Previously, he worked with Aspect Medical Systems (17 yrs.), serving most recently as Vice President of Research. Dr. Greenwald received a B.S. in Engineering jointly from the departments of Biomedical and Electrical Engineering from Duke University, a S.M. in Electrical Engineering and Computer Science from MIT, and a Ph.D. in Medical Engineering from MIT via the Harvard-MIT Division of Health Sciences and Technology.